Rare diseases of the anterior segment of the eye: update on diagnosis and management by Lambiase, Alessandro et al.
Editorial
Rare Diseases of the Anterior Segment of the Eye:
Update on Diagnosis and Management
Alessandro Lambiase,1 Flavio Mantelli,2 Marta Sacchetti,3
Siavash Rahimi,4 and Giacomina Massaro-Giordano5
1Department of Sense Organs, Sapienza University of Rome, Viale del Policlinico, No. 155, 00196 Rome, Italy
2Department of Biology, College of Science and Technology, Temple University, 1900 N. 12th Street, Philadelphia, PA 19122, USA
3Cornea and Ocular Surface Unit, San Raffaele Hospital, Via Olgettina, No. 60, 20132 Milan, Italy
4Queen Alexandra Hospital, Southwick Hill Road, Cosham PO6 3LY, UK
5Scheie Eye Institute, University of Pennsylvania, 51 N. 39th Street, Philadelphia, PA 19104, USA
Correspondence should be addressed to Alessandro Lambiase; alessandro.lambiase@uniroma1.it
Received 17 August 2015; Accepted 24 August 2015
Copyright © 2015 Alessandro Lambiase et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
This special issue is focused on the current approaches used
to identify and manage rare diseases of the anterior segment
of the eye, which range from congenital to acquired disorders
that are caused by ocular or systemic conditions and often
have consequences that extend beyond the anterior segment
of the eye. Specifically, the groups of Dr. R. Cascella et al.
and Dr. G. L. Scuderi et al. provided a complete overview
on primary congenital glaucoma and pediatric glaucoma,
respectively, from diagnosis to treatment outcomes; the
groups of Dr. D. Dobrowolski et al. and Dr. B. E. Ramı´rez
et al. described the use of oral mucosa and stem cell therapy,
respectively, for ocular surface reconstruction in rare diseases
such as aniridia; Dr. F. Mantelli and colleagues reviewed
the diagnosis and management of congenital corneal anes-
thesia and neurotrophic keratitis; Dr. A. K. Nowinska and
colleagues compared different tomographic approaches to
evaluate rare corneal dystrophies; the groups of Dr. M. Ołdak
and Dr. S. P. Patel explained the pathophysiology of Fuchs
endothelial corneal dystrophy and congenital hereditary
endothelial corneal dystrophy, respectively; Dr. M. Sacchetti
and colleagues provide a guide to diagnose and manage
the iridocorneal endothelial (ICE) syndrome; Dr. S. Abdol-
rahimzadeh and colleagues described a series of rare diseases
and ophthalmic alterations that may lead to glaucoma; Dr.
M. F. Sua´rez et al. described how environmental agents can
influence a rare corneal disease, climatic droplet keratopathy.
As can be seen from the variety of topics presented in
this special issue, the disorders grouped under the umbrella
term of rare diseases of the anterior segment of the eye can be
considered quite heterogenous and numerous and, in turn,
represent a substantial clinical burden on a worldwide basis
[1]. In fact, although single disorders are rarely encountered
in clinical practice, when taken together, they are not seldom
seen. In addition, these diseases often represent a clinical
challenge due to the paucity of specific diagnostic criteria
and the lack of specific treatments. In fact, rare disorders
tend to remain orphan drug indications due to the difficulty
of running clinical trials, and surgical approaches are often
inadequate due to concomitant anatomical and congenital
anomalies.
To make the clinical picture of the rare diseases of the
anterior segment of the eye even more difficult to manage,
they often have consequences that extend beyond the anterior
segment and can severely impair vision. Specifically, while
corneal opacities and iris anomalies may directly affect
visual function, several diseases such as iridocorneal angle
anomalies may induce glaucoma with consequent damage to
the optic nerve. In addition, several congenital diseases of
the anterior segment of the eye are also associated with facial
anomalies and othermalformations of intraocular structures,
making this group of disorders particularly complex for
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the ophthalmologist, who encounters obstacles in patients’
management from diagnosis to treatment [2].
The recent advances in translational research, which
are reshaping modern ophthalmology, allowed identifying
the link between different clinical phenotypes and specific
mutations in genes regulating the normal formation and
maturation of the anterior segments of the eye [3]. In
turn, our ability to understand the pathogenesis of rare and
complex ophthalmic diseases has improved and, recently,
novel treatments are being proposed for selected disorders of
the anterior segment. For instance, biotechnology approaches
for the pharmaceutical development of recombinant human
molecules as well as novel procedures for ex vivo expansion
of limbal stem cells may soon open novel therapeutic per-
spectives for patients with previously untreatable corneal dis-
orders [4, 5]. Similarly, pre- and posttest genetic counseling
plays an essential role in the achievement of an appropriate
management of congenital glaucoma, in terms of medical,
social, and psychological impact of the disease [6].
Nevertheless, due to the complexity of most of the rare
anterior segment disorders of the eye, ranging from corneal
disorders such as corneal dystrophies, neurotrophic keratitis,
iridocorneal anomalies, and congenital glaucoma, further
progress is mandatory to exert a significant impact on the
natural history of the diseases [7–10]. Hopefully, the constant
growth of novel diagnostic tools, accompanied by a better
understanding of the disease pathophysiology, will also foster
more preclinical and clinical research in this area of high
medical need.
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